Number of the records: 1  

Cyclic AMP-Elevating Capacity of Adenylate Cyclase Toxin-Hemolysin Is Sufficient for Lung Infection but Not for Full Virulence of Bordetella pertussis

  1. 1.
    SYSNO ASEP0476224
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleCyclic AMP-Elevating Capacity of Adenylate Cyclase Toxin-Hemolysin Is Sufficient for Lung Infection but Not for Full Virulence of Bordetella pertussis
    Author(s) Škopová, Karolína (MBU-M)
    Tomalová, Barbora (MBU-M) ORCID
    Kanchev, Ivan (UMG-J) RID
    Rossmann, Pavel (MBU-M)
    Švédová, Martina (MBU-M)
    Adkins, Irena (MBU-M)
    Bíbová, Ilona (MBU-M) RID
    Tomala, Jakub (MBU-M) RID, ORCID
    Mašín, Jiří (MBU-M) RID, ORCID
    Guiso, N. (FR)
    Osička, Radim (MBU-M) RID, ORCID
    Sedláček, Radislav (UMG-J) RID
    Kovář, Marek (MBU-M) RID, ORCID
    Šebo, Peter (MBU-M) RID, ORCID
    Article numbere00937-16
    Source TitleInfection and Immunity. - : American Society for Microbiology - ISSN 0019-9567
    Roč. 85, č. 6 (2017), s. 1-22
    Number of pages22 s.
    Languageeng - English
    CountryUS - United States
    KeywordsBordetella pertussis ; adenylate cyclase toxin-hemolysin ; cAMP intoxication
    Subject RIVEE - Microbiology, Virology
    OECD categoryMicrobiology
    Subject RIV - cooperationInstitute of Molecular Genetics - Microbiology, Virology
    R&D ProjectsNV16-28126A GA MZd - Ministry of Health (MZ)
    GA13-14547S GA ČR - Czech Science Foundation (CSF)
    GA13-12885S GA ČR - Czech Science Foundation (CSF)
    GA15-09157S GA ČR - Czech Science Foundation (CSF)
    GAP302/12/0460 GA ČR - Czech Science Foundation (CSF)
    LM2015064 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    LM2015040 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    Institutional supportMBU-M - RVO:61388971 ; UMG-J - RVO:68378050
    UT WOS000405937200012
    EID SCOPUS85019930879
    DOI10.1128/IAI.00937-16
    AnnotationThe adenylate cyclase toxin-hemolysin (CyaA, ACT, or AC-Hly) of Bordetella pertussis targets phagocytic cells expressing the complement receptor 3 (CR3, Mac-1, αMbeta2 integrin, or CD11b/CD18). CyaA delivers into cells an N-terminal adenylyl cyclase (AC) enzyme domain that is activated by cytosolic calmodulin and catalyzes unregulated conversion of cellular ATP into cyclic AMP (cAMP), a key second messenger subverting bactericidal activities of phagocytes. In parallel, the hemolysin (Hly) moiety of CyaA forms cation-selective hemolytic pores that permeabilize target cell membranes. We constructed the first B. pertussis mutant secreting a CyaA toxin having an intact capacity to deliver the AC enzyme into CD11b-expressing (CD11b+) host phagocytes but impaired in formation of cell-permeabilizing pores and defective in cAMP elevation in CD11b- cells. The nonhemolytic AC+ Hly- bacteria inhibited the antigen-presenting capacities of coincubated mouse dendritic cells in vitro and skewed their Toll-like receptor (TLR)-triggered maturation toward a tolerogenic phenotype. The AC+ Hly- mutant also infected mouse lungs as efficiently as the parental AC+ Hly+ strain. Hence, elevation of cAMP in CD11b- cells and/or the pore-forming capacity of CyaA were not required for infection of mouse airways. The latter activities were, however, involved in bacterial penetration across the epithelial layer, enhanced neutrophil influx into lung parenchyma during sublethal infections, and the exacerbated lung pathology and lethality of B. pertussis infections at higher inoculation doses (more than 107 CFU/mouse). The pore-forming activity of CyaA further synergized with the cAMP-elevating activity in downregulation of major histocompatibility complex class II (MHC-II) molecules on infiltrating myeloid cells, likely contributing to immune subversion of host defenses by the whooping cough agent.
    WorkplaceInstitute of Microbiology
    ContactEliška Spurná, eliska.spurna@biomed.cas.cz, Tel.: 241 062 231
    Year of Publishing2018
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.